Opportunity ID: 342744

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-22-219
Funding Opportunity Title: Biology of Bladder Cancer (R21 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.393 — Cancer Cause and Prevention Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Jul 26, 2022
Last Updated Date: Nov 20, 2024
Original Closing Date for Applications: Sep 07, 2025
Current Closing Date for Applications: Nov 19, 2024
Archive Date: Dec 19, 2024
Estimated Total Program Funding:
Award Ceiling: $275,000
Award Floor:

Eligibility

Eligible Applicants: Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
State governments
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Independent school districts
City or township governments
Small businesses
Special district governments
County governments
Public and State controlled institutions of higher education
Private institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description:

This Funding Opportunity Announcement (FOA) solicits applications investigating the biology and underlying mechanisms of bladder cancer. Bladder cancer is a significant health problem both in the United States and globally. Because of the high incidence and frequent tumor recurrence, bladder cancer exacts an outsized medical burden. While recent progress has been made in the molecular profiling of bladder cancers and identification of mutated genes, relatively little is known regarding the molecular mechanisms driving initiation, progression, and malignancy of bladder cancer. Furthermore, our understanding of biological processes of the normal bladder at the molecular, cell and organ levels is limited. Fundamental knowledge of how molecular and cellular functions of the bladder are altered in cancer will aid our understanding of bladder cancer biology and interventions. Applications that involve multidisciplinary teams and use clinical specimens or investigate both normal and cancer processes are encouraged.

Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-22-219.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

Version History

Version Modification Description Updated Date
Change to close date Nov 20, 2024
Jul 26, 2022

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-22-219
Funding Opportunity Title: Biology of Bladder Cancer (R21 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.393 — Cancer Cause and Prevention Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Jul 26, 2022
Last Updated Date: Nov 20, 2024
Original Closing Date for Applications: Sep 07, 2025
Current Closing Date for Applications: Nov 19, 2024
Archive Date: Dec 19, 2024
Estimated Total Program Funding:
Award Ceiling: $275,000
Award Floor:

Eligibility

Eligible Applicants: Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
State governments
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Independent school districts
City or township governments
Small businesses
Special district governments
County governments
Public and State controlled institutions of higher education
Private institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description:

This Funding Opportunity Announcement (FOA) solicits applications investigating the biology and underlying mechanisms of bladder cancer. Bladder cancer is a significant health problem both in the United States and globally. Because of the high incidence and frequent tumor recurrence, bladder cancer exacts an outsized medical burden. While recent progress has been made in the molecular profiling of bladder cancers and identification of mutated genes, relatively little is known regarding the molecular mechanisms driving initiation, progression, and malignancy of bladder cancer. Furthermore, our understanding of biological processes of the normal bladder at the molecular, cell and organ levels is limited. Fundamental knowledge of how molecular and cellular functions of the bladder are altered in cancer will aid our understanding of bladder cancer biology and interventions. Applications that involve multidisciplinary teams and use clinical specimens or investigate both normal and cancer processes are encouraged.

Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-22-219.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-22-219
Funding Opportunity Title: Biology of Bladder Cancer (R21 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.393 — Cancer Cause and Prevention Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jul 26, 2022
Last Updated Date: Jul 26, 2022
Original Closing Date for Applications:
Current Closing Date for Applications: Sep 07, 2025
Archive Date: Oct 13, 2025
Estimated Total Program Funding:
Award Ceiling: $275,000
Award Floor:

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Special district governments
Small businesses
County governments
City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
Public housing authorities/Indian housing authorities
Native American tribal governments (Federally recognized)
Independent school districts
Private institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
State governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) solicits applications investigating the biology and underlying mechanisms of bladder cancer. Bladder cancer is a significant health problem both in the United States and globally. Because of the high incidence and frequent tumor recurrence, bladder cancer exacts an outsized medical burden. While recent progress has been made in the molecular profiling of bladder cancers and identification of mutated genes, relatively little is known regarding the molecular mechanisms driving initiation, progression, and malignancy of bladder cancer. Furthermore, our understanding of biological processes of the normal bladder at the molecular, cell and organ levels is limited. Fundamental knowledge of how molecular and cellular functions of the bladder are altered in cancer will aid our understanding of bladder cancer biology and interventions. Applications that involve multidisciplinary teams and use clinical specimens or investigate both normal and cancer processes are encouraged.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-22-219.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

Folder 342744 Full Announcement-PAR-22-219 -> PAR-22-219-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email: OERWebmaster03@od.nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-G Use for due dates on or before January 24, 2023 PKG00276168 Sep 16, 2022 Jan 24, 2023 View
FORMS-H Use for due dates on or after January 25, 2023 PKG00278161 Nov 08, 2022 Nov 21, 2024 View
FORMS-I Use for due dates on or after January 25, 2025 PKG00288892 Nov 08, 2024 Sep 07, 2025 View

Package 1

Mandatory forms

342744 RR_SF424_5_0-5.0.pdf

342744 PHS398_CoverPageSupplement_5_0-5.0.pdf

342744 RR_OtherProjectInfo_1_4-1.4.pdf

342744 PerformanceSite_4_0-4.0.pdf

342744 RR_KeyPersonExpanded_4_0-4.0.pdf

342744 PHS398_ResearchPlan_5_0-5.0.pdf

342744 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

342744 RR_Budget_3_0-3.0.pdf

342744 RR_SubawardBudget30_3_0-3.0.pdf

342744 PHS398_ModularBudget_1_2-1.2.pdf

342744 PHS_AssignmentRequestForm_4_0-4.0.pdf

Package 2

Mandatory forms

342744 RR_SF424_5_0-5.0.pdf

342744 PHS398_CoverPageSupplement_5_0-5.0.pdf

342744 RR_OtherProjectInfo_1_4-1.4.pdf

342744 PerformanceSite_4_0-4.0.pdf

342744 RR_KeyPersonExpanded_4_0-4.0.pdf

342744 PHS398_ResearchPlan_4_0-4.0.pdf

342744 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

342744 RR_Budget_3_0-3.0.pdf

342744 RR_SubawardBudget30_3_0-3.0.pdf

342744 PHS398_ModularBudget_1_2-1.2.pdf

342744 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

342744 RR_SF424_5_0-5.0.pdf

342744 PHS398_CoverPageSupplement_5_0-5.0.pdf

342744 RR_OtherProjectInfo_1_4-1.4.pdf

342744 PerformanceSite_4_0-4.0.pdf

342744 RR_KeyPersonExpanded_4_0-4.0.pdf

342744 PHS398_ResearchPlan_5_0-5.0.pdf

342744 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

342744 RR_Budget_3_0-3.0.pdf

342744 RR_SubawardBudget30_3_0-3.0.pdf

342744 PHS398_ModularBudget_1_2-1.2.pdf

342744 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-13T13:17:30-05:00

Share This Post, Choose Your Platform!

About the Author: